Literature DB >> 18202819

Focal Paraneoplastic Syndrome associated with small cell carcinoma of the lung.

George K Tofaris, Simon F Farmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202819     DOI: 10.1007/s00415-008-0550-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Motor neuron syndromes in cancer patients.

Authors:  P A Forsyth; J Dalmau; F Graus; V Cwik; M K Rosenblum; J B Posner
Journal:  Ann Neurol       Date:  1997-06       Impact factor: 10.422

2.  Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

Authors:  S G Sandler; W Tobin; E S Henderson
Journal:  Neurology       Date:  1969-04       Impact factor: 9.910

3.  Association of subacute motor neuronopathy with thymoma.

Authors:  D B Stoll; F Lublin; H Brodovsky; J F Laucius; A Patchefsky; H Cooper
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

4.  Subacute motor neuronopathy: a remote effect of lymphoma.

Authors:  S C Schold; E S Cho; M Somasundaram; J B Posner
Journal:  Ann Neurol       Date:  1979-03       Impact factor: 10.422

5.  Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma.

Authors:  A Verma; J R Berger; S Snodgrass; C Petito
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

6.  Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation.

Authors:  K R Imrie; F Couture; C C Turner; S B Sutcliffe; A Keating
Journal:  Bone Marrow Transplant       Date:  1994-01       Impact factor: 5.483

  6 in total
  1 in total

Review 1.  Motor neuron disease of paraneoplastic origin: a rare but treatable condition.

Authors:  Nicolas Mélé; Giulia Berzero; Thierry Maisonobe; François Salachas; Guillaume Nicolas; Nicolas Weiss; Guillemette Beaudonnet; Francois Ducray; Dimitri Psimaras; Timothée Lenglet
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.